Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Early and late changes in diabetic kidney disease
- Differences in histology
- Glomerular hypertrophy
- The healthy glomerulus is open in cross-section
- The healthy glomerulus is open in cross-section: microscopy
- The mesangium (is between capillaries)
- Increased mesangial matrix proteins
- Large (mostly) acellular accumulation of matrix (Kimmelstiel-Wilson)
- Other vulnerable cells within the kidney
- Changes in the GBM
- The podocyte on the urine side
- Podocyte de-differentiation
- Advanced diabetic kidney disease
- Tubulointerstitial fibrosis
- Histological staging for diabetic kidney disease
- The presence and severity of CKD is the best and easiest marker of risk in T2D
- CKD increases the risk for premature mortality
- Kidney disease increases risk of CV events and all-cause mortality in patients with T2D
- Increased risk of sudden cardiac death in CKD
- Reduced eGFR = increase CV and total mortality
- Increased uACR = increase CV and total mortality
- The presence and severity of CKD is the best and easiest marker of risk in T2D: MACE
- Kidney disease increases risk of CV events in patients with T2D
- The presence and severity of CKD is the best and easiest marker of risk in T2D: heart failure
- The Swedish Heart Failure Register
- The presence and severity of CKD is the best and easiest marker of risk in T2D
- ESKD is for the lucky survivors!
- Summary
- Thank you for listening
Topics Covered
- Changes in diabetic kidney disease
- Glomerular hypertrophy
- Mesangial expansion
- Thickening of the GBM involves podocyte de-differentiation
- Thickening of Bowman’s capsule
- Glomerular sclerosis
- Arteriolar hyalinosis
- Tubulointerstitial fibrosis
- CDK and increased mortality
Links
Categories:
Therapeutic Areas:
External Links
Talk Citation
Thomas, M. (2023, August 31). Chronic kidney disease in type 2 diabetes: pathology [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 30, 2024, from https://doi.org/10.69645/FEYU4615.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Merlin Thomas has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Chronic kidney disease in type 2 diabetes: pathology
Published on August 31, 2023
24 min
A selection of talks on Immunology & Inflammation
Transcript
Please wait while the transcript is being prepared...
0:04
Having understood the mechanisms
behind why glucose can
cause these changes,
it's really important
to understand what
the changes are
within the kidney.
Then these can be
seen relatively
simply on biopsy or in
experimental studies.
As I mentioned earlier,
one of the earliest
changes that you see in
the diabetic kidney
is an increase in
the size of the kidney with
increasing not only of
the size of tubules,
but also the
glomerular get larger.
There's an expansion
in the amount
of material within
the mesangium,
possibly in response
to podocyte injury as
a way to hold the
glomerulus together.
There's also characteristically
a thickening
of the glomerular
basement membrane.
Again, possibly to
protect the podocytes
from the extra pressure that
they find themselves under,
and thickening of
the Bowman's capsule
surrounding the glomerulus.
Progressively, these changes
can expand and lead
to ultimately,
glomerulus scarring known
as glomerulosclerosis.
The blood vessels adjacent
to the glomeruli become
hyalinized or thickened with
amorphous pink material,
and ultimately, the scarring
involves the
tubulointerstitial as well.
1:21
This slide conceptualizes
the differences in
histology between
a healthy kidney
on the bottom and
an abnormal kidney with
diabetes on the top.
Characteristically, you can see
that in the diabetic kidney,
there is an increased amount of
material within the mesangium,
more cells and more
material within there.
Mesangium essentially
means between
the angium or between
the blood vessels.
The mesangium job
is really to hold
the filtering blood
vessels in their place.
But this mesangium
becomes markedly
expanded in individuals
with diabetes.
Equally, the podocytes
that sit beautifully along
the urinary surface of the
glomerulus become fewer,
and they also become
further spread
out and the tubules become
abnormal and hypertrophied.